in living subjects are often used when 20 interpreting the results of the toxicological analyses. However, 21 such concentrations cannot directly be translated to a postmortem 22 setting [4] [5] [6] [7] . Another problem is that compilations based on 23 postmortem data are a mix of literature reviews and case reports. 24 This is problematic since drug levels that may be observed in cases 25 of death attributed to causes other than intoxication are not 26 commonly included. Furthermore, there are discrepancies in 27 samples chosen for analysis, sampling procedures, analytical 28 methods, selection of cases, and methodological procedures [8] .
29 In Sweden, the blood sampling and handling procedures are Postmortem Intoxication Poisoning Forensic toxicology Toxicity Benzodiazepines
A B S T R A C T
In postmortem investigations of fatal intoxications it is often challenging to determine which drug/s caused the death. To improve the interpretation of postmortem blood concentrations of sedative and hypnotic drugs and/or clonazepam, all medico-legal autopsies in Sweden -where these drugs had been detected in femoral vein blood during 1992-2006 -were Q3 identified in the databases of the National Board of Forensic Medicine. For each drug, concentrations in postmortem control cases -where the cause of death was not intoxication and where incapacitation by drugs could be excluded -were compiled as well as the levels found in living subjects; drugged driving cases and therapeutic drug monitoring cases. Subsequently, fatal intoxications were assessed with regards to the primary substances contributing to death, and blood levels were compiled for single and multiple drug intoxications. The postmortem femoral blood levels are reported for 16 sedative and hypnotic drugs, based on findings in 3560 autopsy cases. The cases were classified as single substance intoxications (N = 498), multiple substance intoxications (N = 1555) and postmortem controls (N = 1507). Each autopsy case could be represented more than once in the group of multiple intoxications and among the postmortem controls if more than one of the included substances were detected. The concentration ranges for all groups are provided. Overlap in concentrations between fatal intoxications and reference groups was seen for most substances. However, the concentrations found in single and multiple intoxications were significantly higher than concentrations found in postmortem controls for all substances except alprazolam and triazolam. Concentrations observed among drugged drivers were similar to the concentrations observed among the therapeutic drug monitoring cases. Flunitrazepam was the substance with the highest number of single intoxications, when related to sales. In summary, this study provides reference drug concentrations primarily to be used for improving interpretation of postmortem drug levels in obscure cases, but which also may assist in drug safety work and in pharmacovigilance efforts. combined forensic medicine and toxicology national database [12] . 67
This constitutes a real-time database and all data are continuously 68 generated from the routine casework data management system for 69 forensic medicine and toxicology. The ICD-9 system, with some 70 supplemental diagnoses to improve specificity, is used to translate 71 causes of death into codes. Based on the cause of death, the cases 72 were divided into three mutually exclusive groups according to a 73 previously described procedure 319 The TDM levels were based on a large collection of analyses of 320 serum samples from patients treated at various medical facilities. 321 To make the concentrations identified in the TDM cohort 322 comparable with the concentrations identified in the DUI and 323 the postmortem cases, the volume unit (nmol/L) was converted to 324 a mass unit (mg/g). Further, the forensic limits of quantification 325 were applied on the TDM results. This implies that subjects with 326 low drug concentrations (probably therapeutic or subtherapeu-327 tic) were excluded. The TDM concentrations presented in this 328 paper is therefore not representative of the whole clinical TDM 329 population. The differences observed between Groups C, D and 330 Group T might partly be explained by differences in matrix used, 331 since it is possible that some of the drugs included show an uneven 332 distribution between serum and the erythrocyte fraction [22] [23] [24] . 
Comparison with previous work

364
The reference values presented in this paper are difficult to 365 compare with other reported concentrations due to major 366 differences in study design. However, for substances where Moreover, some of the substances included in this study are 419 commonly used for ''recreational purposes'' and hence a propor-420 tion of the subjects might have taken these without a prescription. 421
In a Swedish study [42] 
446
The major strengths with this study are the strict inclusion 447 criteria that all postmortem cases included were assessed by two 448 independent reviewers, and that in cases with unexpected high or 449 low concentrations, the original files were scrutinized. Moreover, 450 only femoral venous blood concentrations were considered, and 451 the samples were collected and handled according to a standard-452 ized procedure and analyzed at a single laboratory. Further, for 453 most substances a large number of cases were evaluated and 454 comparisons with previous evaluations using the same strategy 455 showed that the results were robust. 456 However, for some substances the number of cases in one or 457 more groups was low, and their medians and ranges should be 458 used with caution. The low occurrence of these drugs in our 459 postmortem data might be multifactorial. Since many more 460 sedatives and hypnotics are marketed in other parts of the world, 461 we encourage more studies using the same strategy. 
463
In conclusion, this study provides blood reference concentra-464 tions that may assist forensic pathologists and toxicologists in the 465 interpretation of postmortem drug levels.
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